These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Mutter GL Gynecol Oncol; 2000 Mar; 76(3):287-90. PubMed ID: 10684697 [TBL] [Abstract][Full Text] [Related]
3. [The premalignant disease of the endometrium: endometrial intraepithelial neoplasia]. Francz M Magy Onkol; 2008 Mar; 52(1):35-40. PubMed ID: 18403295 [TBL] [Abstract][Full Text] [Related]
6. BCL-2 and PAX2 Expressions in EIN which Had Been Previously Diagnosed as Non-Atypical Hyperplasia. Trabzonlu L; Muezzinoglu B; Corakci A Pathol Oncol Res; 2019 Apr; 25(2):471-476. PubMed ID: 29270778 [TBL] [Abstract][Full Text] [Related]
7. [New views on hyperplastic endometrial lesions classification--endometrial intraepithelial neoplasia (EIN)]. Sobczuk A; Wrona M; Pertyński T Ginekol Pol; 2007 Dec; 78(12):986-9. PubMed ID: 18411925 [TBL] [Abstract][Full Text] [Related]
8. Management of endometrial precancers. Trimble CL; Method M; Leitao M; Lu K; Ioffe O; Hampton M; Higgins R; Zaino R; Mutter GL; Obstet Gynecol; 2012 Nov; 120(5):1160-75. PubMed ID: 23090535 [TBL] [Abstract][Full Text] [Related]
9. A primer of endometrial cytology with histological correlation. Maksem JA; Meiers I; Robboy SJ Diagn Cytopathol; 2007 Dec; 35(12):817-44. PubMed ID: 18008351 [TBL] [Abstract][Full Text] [Related]
10. Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia. Ørbo A; Moe BT; Arnes M; Pettersen I; Larsen K; Eggen T; Myrmel K; Hanssen K Anticancer Res; 2010 Nov; 30(11):4649-55. PubMed ID: 21115919 [TBL] [Abstract][Full Text] [Related]
12. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias. Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462 [TBL] [Abstract][Full Text] [Related]
14. Endometrial hyperplasia and the risk of progression to carcinoma. Lacey JV; Chia VM Maturitas; 2009 May; 63(1):39-44. PubMed ID: 19285814 [TBL] [Abstract][Full Text] [Related]
15. Benign and Premalignant Lesions of the Endometrium. Mallinger WD; Quick CM Surg Pathol Clin; 2019 Jun; 12(2):315-328. PubMed ID: 31097106 [TBL] [Abstract][Full Text] [Related]
16. Pax2 expression in simultaneously diagnosed WHO and EIN classification systems. Joiner AK; Quick CM; Jeffus SK Int J Gynecol Pathol; 2015 Jan; 34(1):40-6. PubMed ID: 25473752 [TBL] [Abstract][Full Text] [Related]
17. New concepts for an old problem: the diagnosis of endometrial hyperplasia. Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066 [TBL] [Abstract][Full Text] [Related]
18. Loss of B-cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment: A systematic review and meta-analysis. Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1415-1426. PubMed ID: 30168854 [TBL] [Abstract][Full Text] [Related]